Device
IOL implantation experimental (ISOPURE 1.2.3.)
IOL implantation experimental (ISOPURE 1.2.3.) is a medical device with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
4
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A4 (100.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
PMCF Study on EDOF (Isopure) vs Monofocal (Micropure) IOL
NCT04249492
completednot_applicable
Comparison of ISOPURE and EYHANCE (Switzerland)
NCT05875922
completednot_applicable
PMCF Study on Comparison of EDOF Lenses (Switzerland)
NCT05235139
completednot_applicable
PMCF Retrospective Study Outcomes of a Premium Monofocal IOL
NCT04874376
Clinical Trials (4)
Showing 4 of 4 trials
NCT04249492Not Applicable
PMCF Study on EDOF (Isopure) vs Monofocal (Micropure) IOL
NCT05875922Not Applicable
Comparison of ISOPURE and EYHANCE (Switzerland)
NCT05235139Not Applicable
PMCF Study on Comparison of EDOF Lenses (Switzerland)
NCT04874376Not Applicable
PMCF Retrospective Study Outcomes of a Premium Monofocal IOL
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4